These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21372006)

  • 41. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.
    Foulks GN; Borchman D; Yappert M; Kakar S
    Cornea; 2013 Jan; 32(1):44-53. PubMed ID: 22668581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposable eyelid-warming device for the treatment of meibomian gland dysfunction.
    Mori A; Shimazaki J; Shimmura S; Fujishima H; Oguchi Y; Tsubota K
    Jpn J Ophthalmol; 2003; 47(6):578-86. PubMed ID: 14636848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction.
    Xue AL; Wang MTM; Ormonde SE; Craig JP
    Ocul Surf; 2020 Apr; 18(2):286-297. PubMed ID: 32007523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment efficacy of dietary supplement Licofor for dry eye associated with meibomian gland dysfunction].
    Peng X; Li YJ; Yau YQ; Liao M; Liu KC; Yuan RL; Cao ZQ; Tang XB; Xu Y; Liang JW; Li QX; Wang H
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(32):2508-2513. PubMed ID: 34407575
    [No Abstract]   [Full Text] [Related]  

  • 45. Rete Ridges in Eyelid Margin and Inflammatory Cytokines in Meibomian Gland Dysfunction Associated with Dry Eye Symptom.
    Li M; Yu Y; Yuan Y; Wang P; Hu X; Zhu C; Ke B
    Curr Eye Res; 2021 Feb; 46(2):202-209. PubMed ID: 32663037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PREVALENCE OF MEIBOMIAN GLAND DYSFUNCTION IN AFRICA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES.
    Akowuah PK; Kobia-Acquah E; Donkor R; Arthur C; Senanu EN; Dadzie EE; Frimpong AA; Otabil FA; Mbilia H; Owusu E; Adjei-Anang J
    Ophthalmic Epidemiol; 2022 Aug; 29(4):374-383. PubMed ID: 34338611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes.
    Ye F; Jiang F; Lu Y; Xue CY; Zhu XM; Wu Y; Huang ZP
    Indian J Ophthalmol; 2019 May; 67(5):599-603. PubMed ID: 31007216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of Meibomian Gland Dysfunction and Friction-Related Disease on the Severity of Dry Eye.
    Vu CHV; Kawashima M; Yamada M; Suwaki K; Uchino M; Shigeyasu C; Hiratsuka Y; Yokoi N; Tsubota K;
    Ophthalmology; 2018 Aug; 125(8):1181-1188. PubMed ID: 29459039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD).
    Hwang HS; Parfitt GJ; Brown DJ; Jester JV
    Exp Eye Res; 2017 Oct; 163():37-45. PubMed ID: 28219733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations.
    Foulks GN; Borchman D; Yappert M; Kim SH; McKay JW
    Cornea; 2010 Jul; 29(7):781-8. PubMed ID: 20489573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraductal meibomian gland probing and its efficacy in the treatment of meibomian gland dysfunction.
    Magno M; Moschowits E; Arita R; Vehof J; Utheim TP
    Surv Ophthalmol; 2021; 66(4):612-622. PubMed ID: 33352147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy.
    Finis D; König C; Hayajneh J; Borrelli M; Schrader S; Geerling G
    Cornea; 2014 Dec; 33(12):1265-70. PubMed ID: 25321941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of dry eye disase and meibomian gland dysfunction with meibography in seborrheic dermatitis.
    Yasar E; Kemeriz F; Gurlevik U
    Cont Lens Anterior Eye; 2019 Dec; 42(6):675-678. PubMed ID: 30922551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meibomian Gland Morphology Is a Sensitive Early Indicator of Meibomian Gland Dysfunction.
    Adil MY; Xiao J; Olafsson J; Chen X; Lagali NS; Ræder S; Utheim ØA; Dartt DA; Utheim TP
    Am J Ophthalmol; 2019 Apr; 200():16-25. PubMed ID: 30578784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface?
    Cermak JM; Krenzer KL; Sullivan RM; Dana MR; Sullivan DA
    Cornea; 2003 Aug; 22(6):516-21. PubMed ID: 12883343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous-deficient dry eye.
    Joffre C; Souchier M; Grégoire S; Viau S; Bretillon L; Acar N; Bron AM; Creuzot-Garcher C
    Br J Ophthalmol; 2008 Jan; 92(1):116-9. PubMed ID: 18156378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of age and dysfunction on human meibomian glands.
    Nien CJ; Massei S; Lin G; Nabavi C; Tao J; Brown DJ; Paugh JR; Jester JV
    Arch Ophthalmol; 2011 Apr; 129(4):462-9. PubMed ID: 21482872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of rabbit models of meibomian gland dysfunction and scope for translational research.
    Prasad D; Salman M; Reddy AA; Jaffet J; Sahoo A; Jakati S; Bokara KK; Singh S; Basu S; Singh V; Donthineni PR
    Indian J Ophthalmol; 2023 Apr; 71(4):1227-1236. PubMed ID: 37026253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Androgen control of gene expression in the mouse meibomian gland.
    Schirra F; Suzuki T; Richards SM; Jensen RV; Liu M; Lombardi MJ; Rowley P; Treister NS; Sullivan DA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3666-75. PubMed ID: 16186348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring Signs and Symptoms Associated with Meibomian Gland Dysfunction for Use as Clinical Trial Endpoints.
    Ajouz L; Nguyen A; Zhao C; Robinson MR; Nichols KK
    J Ocul Pharmacol Ther; 2023 Nov; 39(9):611-621. PubMed ID: 37643299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.